|
The Carpentier-Edwards PERIMOUNT Plus mitral heart valve is the first—and only—biomechanically engineered valve. It combines the latest engineering advancements with the benefits of natural pericardial tissue. - Pericardial tissue and Elgiloy stent material are both known for their optimal intrinsic properties for valve manufacture.
- Integrated processes such as stress-free Neutralogic fixation, PeriMap pericardial thickness mapping technology, and tissue deflection testing enable leaflets to be accurately matched.
- Position-specific design answers the challenging requirements of the mitral position.
- XenoLogiX tissue treatment eliminates up to 98% of phospholipids, a major calcium binding site.*
- Built on the proven long-term durability of the PERIMOUNT valve in the mitral position, as detailed in the 16-year clinical communiqué.
*No clinical data are available which evaluate the long-term impact of the Edwards tissue treatment in patients.
|
|
|
|
|